MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$5,682K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation expense
Inventory
Accrued compensation
Others
Negative Cash Flow Breakdown
Accrued and other current liabil...
Net loss
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-4,446
-12,980
-4,162
-8,169
Depreciation and amortization
94
103
108
105
Accretion of debt discount and debt issuance costs
243
233
230
249
Stock-based compensation expense
2,963
2,853
2,549
2,420
Allowance (benefit) for credit losses
-
-127
101
-33
Provision (benefit) for excess and obsolete inventories
-
-28
3
21
Noncash operating lease expense
109
116
130
127
Loss on disposal of property and equipment
-
-
0
-4
Noncash loss on debt extinguishment
-
-
0
0
Change in fair value of common stock warrants
-
-
11
-
Other
125
-
-
-
Accounts receivable
831
722
102
98
Inventory
-1,321
-788
-214
1,791
Prepaid expenses and other current assets
658
690
-240
926
Other noncurrent assets
255
-102
16
207
Accounts payable
412
143
-398
-335
Accrued compensation
975
-2,383
-118
965
Accrued and other current liabilities
-5,620
5,563
-617
-850
Other noncurrent liabilities
-
-
0
0
Net cash used in operating activities
-5,663
-7,029
-1,827
-8,719
Purchases of property and equipment
19
60
-156
170
Net cash used in investing activities
-19
-60
156
-170
Net proceeds from hercules loan agreement
-
-
0
0
Repayment of midcap loan agreement
-
-
0
0
Debt issuance costs
-
-
0
0
Proceeds from employee stock purchase plan purchases
476
-
325
-1
Taxes paid on net share settlement of restricted stock units
-2
-11
-3
-1
Proceeds from exercise of common stock options
0
99
943
27
Net cash provided by financing activities
474
88
1,265
25
Net change in cash, cash equivalents, and restricted cash
-5,208
-7,001
-406
-8,864
Cash, cash equivalents, and restricted cash at beginning of period
85,229
92,230
92,636
120,357
Cash, cash equivalents, and restrcited cash at end of period
80,021
85,229
92,230
92,636
Restricted cash
268
-
-
-
Cash and cash equivalents at end of period
79,753
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from employee
stock purchase plan...
$476K
(9.68%↑ Y/Y)
Net cash provided by
financing activities
$474K
(-5.39%↓ Y/Y)
Canceled cashflow
$2K
Net change in cash,
cash equivalents,...
-$5,208K
(72.38%↑ Y/Y)
Canceled cashflow
$474K
Stock-based compensation
expense
$2,963K
(-63.35%↓ Y/Y)
Inventory
-$1,321K
(-878.52%↓ Y/Y)
Accrued compensation
$975K
(121.90%↑ Y/Y)
Accounts payable
$412K
(7.01%↑ Y/Y)
Accretion of debt discount
and debt issuance...
$243K
(-47.74%↓ Y/Y)
Noncash operating lease
expense
$109K
(-54.77%↓ Y/Y)
Depreciation and
amortization
$94K
(-65.69%↓ Y/Y)
Taxes paid on net share
settlement of restricted...
-$2K
(96.30%↑ Y/Y)
Net cash used in
operating activities
-$5,663K
(70.43%↑ Y/Y)
Canceled cashflow
$6,117K
Net cash used in
investing activities
-$19K
(90.95%↑ Y/Y)
Accrued and other
current liabilities
-$5,620K
(-1533.67%↓ Y/Y)
Net loss
-$4,446K
(82.96%↑ Y/Y)
Accounts receivable
$831K
(174.73%↑ Y/Y)
Prepaid expenses and
other current assets
$658K
(427.36%↑ Y/Y)
Other noncurrent
assets
$255K
(449.32%↑ Y/Y)
Purchases of property and
equipment
$19K
(-90.95%↓ Y/Y)
Buy us a coffee
Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT)